Vasodilator effects of sulforaphane in cerebral circulation: A critical role of endogenously produced hydrogen sulfide and arteriolar smooth muscle KATP and BK channels in the brain

J Cereb Blood Flow Metab. 2020 Oct;40(10):1987-1996. doi: 10.1177/0271678X19878284. Epub 2019 Oct 9.

Abstract

We investigated the effects of sulforaphane (SFN), an isothiocyanate from cruciferous vegetables, in the regulation of cerebral blood flow using cranial windows in newborn pigs. SFN administered topically (10 µM-1 mM) or systemically (0.4 mg/kg ip) caused immediate and sustained dilation of pial arterioles concomitantly with elevated H2S in periarachnoid cortical cerebrospinal fluid. H2S is a potent vasodilator of cerebral arterioles. SFN is not a H2S donor but it acts via stimulating H2S generation in the brain catalyzed by cystathionine γ-lyase (CSE) and cystathionine β-synthase (CBS). CSE/CBS inhibitors propargylglycine, β-cyano-L-alanine, and aminooxyacetic acid blocked brain H2S generation and cerebral vasodilation caused by SFN. The SFN-elicited vasodilation requires activation of potassium channels in cerebral arterioles. The inhibitors of KATP and BK channels glibenclamide, paxilline, and iberiotoxin blocked the vasodilator effects of topical and systemic SFN, supporting the concept that H2S is the mediator of the vasodilator properties of SFN in cerebral circulation. Overall, we provide first evidence that SFN is a brain permeable compound that increases cerebral blood flow via a non-genomic mechanism that is mediated via activation of CSE/CBS-catalyzed H2S formation in neurovascular cells followed by H2S-induced activation of KATP and BK channels in arteriolar smooth muscle.

Keywords: Cerebral circulation; cranial window; gaseous mediators; hydrogen sulfide; isothiocyanate; newborn pigs; potassium channels.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Animals, Newborn
  • Arterioles / drug effects
  • Arterioles / metabolism*
  • Brain / metabolism
  • Cerebrovascular Circulation / drug effects*
  • Cystathionine beta-Synthase / antagonists & inhibitors
  • Cystathionine beta-Synthase / metabolism
  • Cystathionine gamma-Lyase / antagonists & inhibitors
  • Cystathionine gamma-Lyase / metabolism
  • Enzyme Inhibitors / pharmacology
  • Female
  • Hydrogen Sulfide / metabolism*
  • Isothiocyanates / antagonists & inhibitors
  • Isothiocyanates / pharmacology*
  • KATP Channels / drug effects
  • KATP Channels / metabolism*
  • Large-Conductance Calcium-Activated Potassium Channels / drug effects
  • Large-Conductance Calcium-Activated Potassium Channels / metabolism*
  • Male
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / metabolism*
  • Myocytes, Smooth Muscle / drug effects
  • Myocytes, Smooth Muscle / metabolism
  • Sulfoxides
  • Swine
  • Vasodilator Agents / pharmacology*

Substances

  • Enzyme Inhibitors
  • Isothiocyanates
  • KATP Channels
  • Large-Conductance Calcium-Activated Potassium Channels
  • Sulfoxides
  • Vasodilator Agents
  • Cystathionine beta-Synthase
  • Cystathionine gamma-Lyase
  • sulforaphane
  • Hydrogen Sulfide